HEADER TRANSFERASE 14-MAY-07 2PX8 TITLE CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O TITLE 2 METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAH AND 7M-GTP COMPND MOL_ID: 1; COMPND 2 MOLECULE: GENOME POLYPROTEIN [CONTAINS: CAPSID PROTEIN C (CORE COMPND 3 PROTEIN); ENVELOPE PROTEIN M (MATRIX PROTEIN); MAJOR ENVELOPE PROTEIN COMPND 4 E; NON-STRUCTURAL PROTEIN 1 (NS1); NON-STRUCTURAL PROTEIN 2A (NS2A); COMPND 5 FLAVIVIRIN PROTEASE NS2B REGULATORY SUBUNIT; FLAVIVIRIN PROTEASE NS3 COMPND 6 CATALYTIC SUBUNIT; NON-STRUCTURAL PROTEIN 4A (NS4A); NON-STRUCTURAL COMPND 7 PROTEIN 4B (NS4B); RNA-DIRECTED RNA POLYMERASE (EC 2.7.7.48) (NS5)]; COMPND 8 CHAIN: A, B; COMPND 9 FRAGMENT: NS5 2'-O METHYLTRANSFERASE DOMAIN: RESIDUES 2530-2798; COMPND 10 EC: 2.7.7.48; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MURRAY VALLEY ENCEPHALITIS VIRUS (STRAIN MVE-1- SOURCE 3 51); SOURCE 4 ORGANISM_TAXID: 301478; SOURCE 5 STRAIN: MVE-1-51, MVEV; SOURCE 6 GENE: NS5; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: ROSETTA(DE3)PLYSS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: OPPF2936 KEYWDS MURRAY VALLEY ENCEPHALITIS VIRUS, METHYLTRANSFERASE, SAH, 7M-GTP, KEYWDS 2 3PO, STRUCTURAL GENOMICS, OXFORD PROTEIN PRODUCTION FACILITY, OPPF, KEYWDS 3 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.ASSENBERG,J.REN,A.VERMA,T.S.WALTER,D.ALDERTON,R.J.HURRELBRINK, AUTHOR 2 S.D.FULLER,R.J.OWENS,D.I.STUART,J.M.GRIMES,OXFORD PROTEIN PRODUCTION AUTHOR 3 FACILITY (OPPF) REVDAT 5 30-AUG-23 2PX8 1 REMARK SEQADV LINK REVDAT 4 13-JUL-11 2PX8 1 VERSN REVDAT 3 24-FEB-09 2PX8 1 VERSN REVDAT 2 24-JUL-07 2PX8 1 JRNL REVDAT 1 29-MAY-07 2PX8 0 JRNL AUTH R.ASSENBERG,J.REN,A.VERMA,T.S.WALTER,D.ALDERTON, JRNL AUTH 2 R.J.HURRELBRINK,S.D.FULLER,S.BRESSANELLI,R.J.OWENS, JRNL AUTH 3 D.I.STUART,J.M.GRIMES JRNL TITL CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS JRNL TITL 2 NS5 METHYLTRANSFERASE DOMAIN IN COMPLEX WITH CAP ANALOGUES. JRNL REF J.GEN.VIROL. V. 88 2228 2007 JRNL REFN ISSN 0022-1317 JRNL PMID 17622627 JRNL DOI 10.1099/VIR.0.82757-0 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 3 NUMBER OF REFLECTIONS : 27752 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.166 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1460 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1424 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 66.73 REMARK 3 BIN R VALUE (WORKING SET) : 0.2060 REMARK 3 BIN FREE R VALUE SET COUNT : 78 REMARK 3 BIN FREE R VALUE : 0.3300 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4206 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 190 REMARK 3 SOLVENT ATOMS : 427 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.97000 REMARK 3 B22 (A**2) : 4.27000 REMARK 3 B33 (A**2) : -2.30000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.287 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.206 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.142 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.239 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.931 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4488 ; 0.007 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6071 ; 1.379 ; 2.022 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 527 ; 4.495 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 192 ;31.806 ;22.708 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 764 ;14.092 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 44 ;10.719 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 628 ; 0.066 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3289 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2101 ; 0.182 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2994 ; 0.296 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 365 ; 0.119 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 107 ; 0.208 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 27 ; 0.113 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2700 ; 2.938 ; 4.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4198 ; 3.984 ; 6.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2129 ; 5.485 ; 6.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1873 ; 8.454 ;10.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 5 A 267 5 REMARK 3 1 B 5 B 267 5 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 1052 ; 0.18 ; 0.50 REMARK 3 LOOSE POSITIONAL 1 A (A): 1042 ; 0.51 ; 5.00 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1052 ; 2.48 ; 20.00 REMARK 3 LOOSE THERMAL 1 A (A**2): 1042 ; 3.66 ; 30.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 4 A 267 REMARK 3 ORIGIN FOR THE GROUP (A): 10.0100 -20.4190 -2.7780 REMARK 3 T TENSOR REMARK 3 T11: -0.1366 T22: -0.1801 REMARK 3 T33: -0.1074 T12: -0.0048 REMARK 3 T13: -0.0009 T23: 0.0073 REMARK 3 L TENSOR REMARK 3 L11: 1.8322 L22: 0.5842 REMARK 3 L33: 2.8282 L12: -0.0554 REMARK 3 L13: 0.8179 L23: 0.1670 REMARK 3 S TENSOR REMARK 3 S11: 0.0197 S12: 0.0365 S13: 0.0105 REMARK 3 S21: -0.0362 S22: -0.0293 S23: 0.0605 REMARK 3 S31: 0.0444 S32: -0.1012 S33: 0.0096 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 5 B 269 REMARK 3 ORIGIN FOR THE GROUP (A): -18.7520 -20.2280 -48.3530 REMARK 3 T TENSOR REMARK 3 T11: -0.1462 T22: -0.1680 REMARK 3 T33: -0.1268 T12: -0.0141 REMARK 3 T13: 0.0184 T23: -0.0198 REMARK 3 L TENSOR REMARK 3 L11: 1.4180 L22: 0.3577 REMARK 3 L33: 2.4505 L12: -0.1440 REMARK 3 L13: 0.9150 L23: -0.0281 REMARK 3 S TENSOR REMARK 3 S11: 0.0549 S12: 0.0227 S13: -0.0528 REMARK 3 S21: -0.0021 S22: -0.0239 S23: 0.0090 REMARK 3 S31: 0.1006 S32: 0.0328 S33: -0.0310 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. CNS PROGRAM HAS ALSO BEEN USED IN REFINEMENT REMARK 4 REMARK 4 2PX8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-MAY-07. REMARK 100 THE DEPOSITION ID IS D_1000042879. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-FEB-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95350 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29231 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.12600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 68.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 0.47200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2PX2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM CHLORIDE, 0.1 M BIS-TRIS REMARK 280 PH 6.5, 25 % W/V PEG 3350, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.78950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.45700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.72250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 50.45700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.78950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.72250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 ARG A 2 REMARK 465 ALA A 3 REMARK 465 GLY A 268 REMARK 465 LYS A 269 REMARK 465 GLY B 1 REMARK 465 ARG B 2 REMARK 465 ALA B 3 REMARK 465 GLY B 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MGT A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MGT B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MGT B 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3PO A 451 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3PO B 452 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH B 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 463 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 468 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2PX2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O REMARK 900 METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAH (MONOCLINIC FORM 1) REMARK 900 RELATED ID: 2PX4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O REMARK 900 METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAH (MONOCLINIC FORM 2) REMARK 900 RELATED ID: 2PX5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O REMARK 900 METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAH (ORTHORHOMBIC CRYSTAL REMARK 900 FORM) REMARK 900 RELATED ID: 2PXA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O REMARK 900 METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAH AND GTPG REMARK 900 RELATED ID: 2PXC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O REMARK 900 METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAM AND GTPA DBREF 2PX8 A 1 269 UNP P05769 POLG_MVEV5 2530 2798 DBREF 2PX8 B 1 269 UNP P05769 POLG_MVEV5 2530 2798 SEQADV 2PX8 MLY A 15 UNP P05769 LYS 2544 MODIFIED RESIDUE SEQADV 2PX8 MLY A 76 UNP P05769 LYS 2605 MODIFIED RESIDUE SEQADV 2PX8 MLY A 95 UNP P05769 LYS 2624 MODIFIED RESIDUE SEQADV 2PX8 MLY A 105 UNP P05769 LYS 2634 MODIFIED RESIDUE SEQADV 2PX8 MLY B 15 UNP P05769 LYS 2544 MODIFIED RESIDUE SEQADV 2PX8 MLY B 76 UNP P05769 LYS 2605 MODIFIED RESIDUE SEQADV 2PX8 MLY B 95 UNP P05769 LYS 2624 MODIFIED RESIDUE SEQADV 2PX8 MLY B 105 UNP P05769 LYS 2634 MODIFIED RESIDUE SEQRES 1 A 269 GLY ARG ALA GLY GLY ARG THR LEU GLY GLU GLN TRP LYS SEQRES 2 A 269 GLU MLY LEU ASN ALA MET GLY LYS GLU GLU PHE PHE SER SEQRES 3 A 269 TYR ARG LYS GLU ALA ILE LEU GLU VAL ASP ARG THR GLU SEQRES 4 A 269 ALA ARG ARG ALA ARG ARG GLU GLY ASN LYS VAL GLY GLY SEQRES 5 A 269 HIS PRO VAL SER ARG GLY THR ALA LYS LEU ARG TRP LEU SEQRES 6 A 269 VAL GLU ARG ARG PHE VAL GLN PRO ILE GLY MLY VAL VAL SEQRES 7 A 269 ASP LEU GLY CYS GLY ARG GLY GLY TRP SER TYR TYR ALA SEQRES 8 A 269 ALA THR MET MLY ASN VAL GLN GLU VAL ARG GLY TYR THR SEQRES 9 A 269 MLY GLY GLY PRO GLY HIS GLU GLU PRO MET LEU MET GLN SEQRES 10 A 269 SER TYR GLY TRP ASN ILE VAL THR MET LYS SER GLY VAL SEQRES 11 A 269 ASP VAL PHE TYR LYS PRO SER GLU ILE SER ASP THR LEU SEQRES 12 A 269 LEU CYS ASP ILE GLY GLU SER SER PRO SER ALA GLU ILE SEQRES 13 A 269 GLU GLU GLN ARG THR LEU ARG ILE LEU GLU MET VAL SER SEQRES 14 A 269 ASP TRP LEU SER ARG GLY PRO LYS GLU PHE CYS ILE LYS SEQRES 15 A 269 ILE LEU CYS PRO TYR MET PRO LYS VAL ILE GLU LYS LEU SEQRES 16 A 269 GLU SER LEU GLN ARG ARG PHE GLY GLY GLY LEU VAL ARG SEQRES 17 A 269 VAL PRO LEU SER ARG ASN SER ASN HIS GLU MET TYR TRP SEQRES 18 A 269 VAL SER GLY ALA SER GLY ASN ILE VAL HIS ALA VAL ASN SEQRES 19 A 269 MET THR SER GLN VAL LEU ILE GLY ARG MET ASP LYS LYS SEQRES 20 A 269 ILE TRP LYS GLY PRO LYS TYR GLU GLU ASP VAL ASN LEU SEQRES 21 A 269 GLY SER GLY THR ARG ALA VAL GLY LYS SEQRES 1 B 269 GLY ARG ALA GLY GLY ARG THR LEU GLY GLU GLN TRP LYS SEQRES 2 B 269 GLU MLY LEU ASN ALA MET GLY LYS GLU GLU PHE PHE SER SEQRES 3 B 269 TYR ARG LYS GLU ALA ILE LEU GLU VAL ASP ARG THR GLU SEQRES 4 B 269 ALA ARG ARG ALA ARG ARG GLU GLY ASN LYS VAL GLY GLY SEQRES 5 B 269 HIS PRO VAL SER ARG GLY THR ALA LYS LEU ARG TRP LEU SEQRES 6 B 269 VAL GLU ARG ARG PHE VAL GLN PRO ILE GLY MLY VAL VAL SEQRES 7 B 269 ASP LEU GLY CYS GLY ARG GLY GLY TRP SER TYR TYR ALA SEQRES 8 B 269 ALA THR MET MLY ASN VAL GLN GLU VAL ARG GLY TYR THR SEQRES 9 B 269 MLY GLY GLY PRO GLY HIS GLU GLU PRO MET LEU MET GLN SEQRES 10 B 269 SER TYR GLY TRP ASN ILE VAL THR MET LYS SER GLY VAL SEQRES 11 B 269 ASP VAL PHE TYR LYS PRO SER GLU ILE SER ASP THR LEU SEQRES 12 B 269 LEU CYS ASP ILE GLY GLU SER SER PRO SER ALA GLU ILE SEQRES 13 B 269 GLU GLU GLN ARG THR LEU ARG ILE LEU GLU MET VAL SER SEQRES 14 B 269 ASP TRP LEU SER ARG GLY PRO LYS GLU PHE CYS ILE LYS SEQRES 15 B 269 ILE LEU CYS PRO TYR MET PRO LYS VAL ILE GLU LYS LEU SEQRES 16 B 269 GLU SER LEU GLN ARG ARG PHE GLY GLY GLY LEU VAL ARG SEQRES 17 B 269 VAL PRO LEU SER ARG ASN SER ASN HIS GLU MET TYR TRP SEQRES 18 B 269 VAL SER GLY ALA SER GLY ASN ILE VAL HIS ALA VAL ASN SEQRES 19 B 269 MET THR SER GLN VAL LEU ILE GLY ARG MET ASP LYS LYS SEQRES 20 B 269 ILE TRP LYS GLY PRO LYS TYR GLU GLU ASP VAL ASN LEU SEQRES 21 B 269 GLY SER GLY THR ARG ALA VAL GLY LYS MODRES 2PX8 MLY A 15 LYS N-DIMETHYL-LYSINE MODRES 2PX8 MLY A 76 LYS N-DIMETHYL-LYSINE MODRES 2PX8 MLY A 95 LYS N-DIMETHYL-LYSINE MODRES 2PX8 MLY A 105 LYS N-DIMETHYL-LYSINE MODRES 2PX8 MLY B 15 LYS N-DIMETHYL-LYSINE MODRES 2PX8 MLY B 76 LYS N-DIMETHYL-LYSINE MODRES 2PX8 MLY B 95 LYS N-DIMETHYL-LYSINE MODRES 2PX8 MLY B 105 LYS N-DIMETHYL-LYSINE HET MLY A 15 11 HET MLY A 76 11 HET MLY A 95 11 HET MLY A 105 11 HET MLY B 15 11 HET MLY B 76 11 HET MLY B 95 11 HET MLY B 105 11 HET MGT A 401 33 HET 3PO A 451 13 HET SAH A 500 26 HET GOL A 463 6 HET CL B 502 1 HET MGT B 402 33 HET MGT B 403 33 HET 3PO B 452 13 HET SAH B 500 26 HET GOL B 468 6 HETNAM MLY N-DIMETHYL-LYSINE HETNAM MGT 7N-METHYL-8-HYDROGUANOSINE-5'-TRIPHOSPHATE HETNAM 3PO TRIPHOSPHATE HETNAM SAH S-ADENOSYL-L-HOMOCYSTEINE HETNAM GOL GLYCEROL HETNAM CL CHLORIDE ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 MLY 8(C8 H18 N2 O2) FORMUL 3 MGT 3(C11 H20 N5 O14 P3) FORMUL 4 3PO 2(H5 O10 P3) FORMUL 5 SAH 2(C14 H20 N6 O5 S) FORMUL 6 GOL 2(C3 H8 O3) FORMUL 7 CL CL 1- FORMUL 13 HOH *427(H2 O) HELIX 1 1 THR A 7 MET A 19 1 13 HELIX 2 2 GLY A 20 LYS A 29 1 10 HELIX 3 3 ARG A 37 GLY A 47 1 11 HELIX 4 4 ARG A 57 ARG A 68 1 12 HELIX 5 5 GLY A 85 ALA A 92 1 8 HELIX 6 6 GLY A 120 ASN A 122 5 3 HELIX 7 7 SER A 153 SER A 173 1 21 HELIX 8 8 MET A 188 GLY A 203 1 16 HELIX 9 9 ASN A 228 ARG A 243 1 16 HELIX 10 10 THR B 7 MET B 19 1 13 HELIX 11 11 GLY B 20 LYS B 29 1 10 HELIX 12 12 ARG B 37 GLY B 47 1 11 HELIX 13 13 ARG B 57 GLU B 67 1 11 HELIX 14 14 GLY B 85 ALA B 92 1 8 HELIX 15 15 GLY B 120 ASN B 122 5 3 HELIX 16 16 SER B 153 SER B 173 1 21 HELIX 17 17 MET B 188 GLY B 203 1 16 HELIX 18 18 ASN B 228 ARG B 243 1 16 SHEET 1 A 2 LEU A 33 VAL A 35 0 SHEET 2 A 2 LYS A 253 GLU A 255 1 O LYS A 253 N GLU A 34 SHEET 1 B 7 VAL A 124 LYS A 127 0 SHEET 2 B 7 VAL A 97 TYR A 103 1 N GLY A 102 O LYS A 127 SHEET 3 B 7 GLY A 75 LEU A 80 1 N VAL A 77 O GLU A 99 SHEET 4 B 7 THR A 142 CYS A 145 1 O LEU A 144 N VAL A 78 SHEET 5 B 7 GLU A 178 ILE A 183 1 O LYS A 182 N CYS A 145 SHEET 6 B 7 MET A 219 VAL A 222 -1 O MET A 219 N ILE A 183 SHEET 7 B 7 GLY A 205 VAL A 207 -1 N VAL A 207 O TYR A 220 SHEET 1 C 2 LEU B 33 VAL B 35 0 SHEET 2 C 2 LYS B 253 GLU B 255 1 O LYS B 253 N GLU B 34 SHEET 1 D 7 VAL B 124 LYS B 127 0 SHEET 2 D 7 ASN B 96 TYR B 103 1 N GLY B 102 O LYS B 127 SHEET 3 D 7 ILE B 74 LEU B 80 1 N VAL B 77 O GLU B 99 SHEET 4 D 7 THR B 142 CYS B 145 1 O LEU B 144 N VAL B 78 SHEET 5 D 7 GLU B 178 ILE B 183 1 O LYS B 182 N CYS B 145 SHEET 6 D 7 MET B 219 VAL B 222 -1 O MET B 219 N ILE B 183 SHEET 7 D 7 GLY B 205 VAL B 207 -1 N VAL B 207 O TYR B 220 LINK C GLU A 14 N MLY A 15 1555 1555 1.33 LINK C MLY A 15 N LEU A 16 1555 1555 1.33 LINK C GLY A 75 N MLY A 76 1555 1555 1.33 LINK C MLY A 76 N VAL A 77 1555 1555 1.33 LINK C MET A 94 N MLY A 95 1555 1555 1.33 LINK C MLY A 95 N ASN A 96 1555 1555 1.33 LINK C THR A 104 N MLY A 105 1555 1555 1.33 LINK C MLY A 105 N GLY A 106 1555 1555 1.33 LINK C GLU B 14 N MLY B 15 1555 1555 1.33 LINK C MLY B 15 N LEU B 16 1555 1555 1.33 LINK C GLY B 75 N MLY B 76 1555 1555 1.33 LINK C MLY B 76 N VAL B 77 1555 1555 1.33 LINK C MET B 94 N MLY B 95 1555 1555 1.33 LINK C MLY B 95 N ASN B 96 1555 1555 1.33 LINK C THR B 104 N MLY B 105 1555 1555 1.33 LINK C MLY B 105 N GLY B 106 1555 1555 1.33 SITE 1 AC1 3 ASN B 17 TYR B 119 ALA B 266 SITE 1 AC2 18 LYS A 13 LEU A 16 ASN A 17 MET A 19 SITE 2 AC2 18 PHE A 24 ARG A 28 MLY A 95 ASN A 96 SITE 3 AC2 18 SER A 150 SER A 151 PRO A 152 ARG A 213 SITE 4 AC2 18 SER A 215 GOL A 463 HOH A 679 HOH A 725 SITE 5 AC2 18 HOH A 750 HOH A 759 SITE 1 AC3 18 LYS B 13 LEU B 16 ASN B 17 MET B 19 SITE 2 AC3 18 LYS B 21 PHE B 24 ARG B 28 MLY B 95 SITE 3 AC3 18 ASN B 96 SER B 150 SER B 151 PRO B 152 SITE 4 AC3 18 ARG B 213 SER B 215 ASN B 216 GOL B 468 SITE 5 AC3 18 HOH B 532 HOH B 672 SITE 1 AC4 5 SER A 197 ARG A 201 GLU B 22 PHE B 25 SITE 2 AC4 5 HOH B 729 SITE 1 AC5 8 ARG A 37 ARG A 41 VAL A 55 SER A 56 SITE 2 AC5 8 ARG A 57 ARG A 84 HOH A 682 HOH A 921 SITE 1 AC6 7 ARG B 37 ARG B 41 VAL B 55 SER B 56 SITE 2 AC6 7 ARG B 57 ARG B 84 HOH B 844 SITE 1 AC7 19 SER A 56 GLY A 58 GLY A 81 CYS A 82 SITE 2 AC7 19 GLY A 83 GLY A 86 TRP A 87 MLY A 105 SITE 3 AC7 19 HIS A 110 GLU A 111 VAL A 130 ASP A 131 SITE 4 AC7 19 VAL A 132 PHE A 133 ASP A 146 HOH A 503 SITE 5 AC7 19 HOH A 505 HOH A 556 HOH A 746 SITE 1 AC8 21 SER B 56 GLY B 58 GLY B 81 CYS B 82 SITE 2 AC8 21 GLY B 83 GLY B 86 TRP B 87 MLY B 105 SITE 3 AC8 21 HIS B 110 GLU B 111 VAL B 130 ASP B 131 SITE 4 AC8 21 VAL B 132 PHE B 133 ASP B 146 ILE B 147 SITE 5 AC8 21 GLU B 149 HOH B 510 HOH B 512 HOH B 516 SITE 6 AC8 21 HOH B 619 SITE 1 AC9 5 ASN A 17 MLY A 95 PRO A 152 ARG A 265 SITE 2 AC9 5 MGT A 401 SITE 1 BC1 11 ASN B 17 MLY B 95 VAL B 97 GLN B 98 SITE 2 BC1 11 ARG B 265 ALA B 266 VAL B 267 GLY B 268 SITE 3 BC1 11 MGT B 402 HOH B 513 HOH B 672 CRYST1 67.579 87.445 100.914 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014797 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011436 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009909 0.00000